Cohort of Patients With NSCLC Treated With Nivolumab Under the ATU Program

Clinical trial NCT02933346 · COMPLETED

Trial details

NCT number: NCT02933346
Sponsor: Intergroupe Francophone de Cancerologie Thoracique
Status: COMPLETED
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer Nivolumab Long-term Adverse Effects

Start date: 2016-09-01
Primary completion: 2018-01-01
Enrollment: 907

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.